Gupta Sandeep, Kalra Nidhi, Singh Ankita, Mishra Avinash, Kaushik Jaya
Department of Ophthalmology, Military Hospital Suratgarh, Rajasthan, India.
Department of Ophthalmology, Base Hospital Guwahati, Assam, India.
Rom J Ophthalmol. 2025 Jan-Mar;69(1):74-82. doi: 10.22336/rjo.2025.13.
This study aimed to compare the safety and efficacy of toric intra ocular lens (IOL) implantation vs. opposite clear corneal incision (OCCI) during cataract surgery to correct preexisting corneal astigmatism in patients with age related cataract by comparing the postoperative residual astigmatism, the uncorrected distance visual acuity and the adverse effects following both the procedures.
A pilot prospective study was conducted at a tertiary hospital among patients undergoing cataract surgery over two years. A total of 150 eyes with pre-existing corneal astigmatism between 1 to 2.5 D were divided into two groups of 75 each by permuted block randomization. Group A underwent implantation of (Alcon Labs, Fort Worth, Tx), and Group B underwent implantation of normal non-toric aspheric OCCI on steep axis. Both groups were followed up for 24 weeks.
In the OCCI Group, the difference between mean K1-K2 preoperative and 12 weeks postoperative (mean ± SD) of patients was 1.55 ± 0.17D. In the TORIC IOL Group, the difference between the mean K1-K2 preoperative and 12-week postoperative values (mean ± SD) for patients was 0.53 ± 0.11. The difference in mean K1-K2 pre-operatively and at 12 weeks was statistically significant for both groups (p < 0.0001). There was a significant reduction in corneal astigmatism in the OCCI group at 01 week.
In our study, the difference in mean K1-K2 at 1 week between the two Groups was statistically significant (p < 0.0001), as OCCI acts directly on the corneal plane, whereas Toric IOLs reduce astigmatism at the lens plane without affecting corneal curvature. There was a significant reduction in corneal astigmatism in the OCCI group at 1 week. This reduction continued to stabilize at 12 weeks. The corneal astigmatism remained stable in the post-operative period in the Toric IOL group. The decrease in astigmatism was more significant in the toric IOL group than in the OCCI group.
These results demonstrate a similar efficacy of OCCI in reducing corneal astigmatism of up to 1.5 D compared to Toric IOLs. The uncorrected visual acuity was superior in the Toric IOL group. However, this difference was reduced significantly by 12 weeks.
本研究旨在通过比较白内障手术中植入散光人工晶状体(IOL)与对侧透明角膜切口(OCCI)矫正年龄相关性白内障患者术前角膜散光的安全性和有效性,比较两种手术术后的残余散光、未矫正远视力及不良反应。
在一家三级医院对两年内接受白内障手术的患者进行前瞻性初步研究。将150只术前角膜散光在1至2.5 D之间的眼睛通过排列分组随机化分为两组,每组75只。A组植入(爱尔康实验室,沃思堡,德克萨斯州),B组在陡峭轴向上进行正常非散光非球面IOL的对侧透明角膜切口植入。两组均随访24周。
在OCCI组中,患者术前平均K1 - K2与术后12周的差异(均值±标准差)为1.55±0.17D。在散光IOL组中,患者术前平均K1 - K2与术后12周值(均值±标准差)的差异为0.53±0.11。两组术前与12周时平均K1 - K2的差异均具有统计学意义(p < 0.0001)。OCCI组在术后1周角膜散光有显著降低。
在我们的研究中,两组在术后1周时平均K1 - K2的差异具有统计学意义(p < 0.0001),因为OCCI直接作用于角膜平面,而散光IOL在晶状体平面减少散光,不影响角膜曲率。OCCI组在术后1周角膜散光有显著降低。这种降低在12周时持续稳定。散光IOL组术后角膜散光保持稳定。散光IOL组散光的降低比OCCI组更显著。
这些结果表明,与散光IOL相比,OCCI在降低高达1.5 D的角膜散光方面具有相似的疗效。散光IOL组的未矫正视力更好。然而,这种差异在12周时显著减小。